$WUXI APPTEC (02359.HK)$, whose net profit rose 21% in 2023, delayed two placing-funded investment projects by 2 years to the end of 2025, and its share price lost 2.8% to $41.55, while its same series$WUXI BIO (02269.HK)$cascaded 3.9%. Pharma SINO BIOPHARM$SINO BIOPHARM (01177.HK)$also dropped 2.8%.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.